Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …

Anaplastic thyroid carcinoma (ATC) is an orphan disease and in most patients fatal. So far
no established treatment is available that prolongs survival. Several large retrospective …

Thyroid cancer is one of the most common endocrine cancers, with an increasing trend in
the last few decades. Although papillary thyroid cancer is the most frequent subtype …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Background Anaplastic thyroid cancer (ATC) represents a rare, aggressive malignancy. We
analyzed factors predictive for overall survival (OS) and treatment modality utilization …

Context: Anaplastic thyroid cancer (ATC) is rare and a highly fatal malignancy. The role of
programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) as prognostic and/or …

Context Historical outcomes in anaplastic thyroid cancer (ATC) have been dismal. Objective
To determine whether an initial intensive multimodal therapy (MMT) is associated with …

Background: Anaplastic thyroid cancer (ATC) has poor prognosis with median overall
survival (OS) of∼ 6 months. We previously reported high PD-1/PDL-1 staining in ATC …

Anaplastic thyroid carcinoma is an uncommon carcinoma representing 1 to 4% of all thyroid
cancers. The carcinoma is most common in females of the eight decades. It is a locally …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were …